Michelon Francois Roger 4
4 · ENDRA Life Sciences Inc. · Filed Jun 24, 2020
Insider Transaction Report
Form 4
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Exercise of In-Money
Common Stock
2020-06-23$0.87/sh+2,874$2,500→ 163,610 total - Exercise of In-Money
Warrants
2020-06-23−2,874→ 2,152 totalExercise: $0.87From: 2019-12-11Exp: 2024-12-11→ Common Stock (2,874 underlying)
Footnotes (1)
- [F1]Includes unvested restricted stock units.